383 results on '"Eyal, Nir"'
Search Results
2. Broad cross-national public support for accelerated COVID-19 vaccine trial designs
3. “Cure” Versus “Clinical Remission”: The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication
4. Mass drug administration of azithromycin: an analysis
5. Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A Symposium
6. Dual-use research and research using enhanced pathogens in high-income countries: whose business?
7. Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines
8. Ethical issues in HIV remission trials
9. “Thought provoking”, “interactive”, and “more like a peer talk”: Testing the deliberative interview style in Germany
10. It’s ethical to test promising coronavirus vaccines against less-promising ones
11. Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events
12. Electronic Adherence Monitoring May Facilitate Intentional HIV Status Disclosure Among People Living with HIV in Rural Southwestern Uganda
13. Adding Lithium to Drinking Water for Suicide Prevention—The Ethics
14. HIV Cure Research : Risks Patients Expressed Willingness to Accept
15. Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies
16. Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure
17. International AIDS Society global scientific strategy: towards an HIV cure 2016
18. AIDS Activism and Coronavirus Vaccine Challenge Trials
19. The establishment of a microvascular free flap service in a medium-sized hospital (500 beds)—an eight-year experience
20. Risk to study nonparticipants : A procedural approach
21. What can the lived experience of participating in risky HIV cure-related studies establish?
22. Inequality in Political Philosophy and in Epidemiology : A Remarriage
23. Invited Commentary on Dubé et al. (Perceptions of Equipoise, Risk/Benefit Ratios, and “Otherwise Healthy Volunteers” in the Context of Early-Phase HIV Cure Research in the United States—A Qualitative Inquiry) : Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy?
24. Can Rationing through INCONVENIENCE Be Ethical?
25. A new day for human challenge trials?
26. Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere
27. Overcoming HIV Stigma? A Qualitative Analysis of HIV Cure Research and Stigma Among Men Who Have Sex with Men Living with HIV
28. Vaccine testing for emerging infections: the case for individual randomisation
29. Improving vaccine trials in infectious disease emergencies
30. Paying for antiretroviral adherence: is it unethical when the patient is an adolescent?
31. Afterword: returning to philosophical foundations in research ethics
32. The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction
33. How to keep high-risk studies ethical: classifying candidate solutions
34. Three Case Studies in Making Fair Choices on the Path to Universal Health Coverage
35. Incommensurability and Trade
36. "Non-consequentialist Utilitarianism"
37. Escitalopram or novel herbal treatments differentially alter cytokine and behavioral responses to immune challenge
38. When offering a patient beneficial treatment undermines public health.
39. Ethical and legal race‐responsive vaccine allocation.
40. Reply
41. Joint statement in support of hepatitis C human challenge studies
42. Correction to: Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere
43. Standard of care versus second-best: Ethical dilemmas in surgery for high risk papillary thyroid cancer in low and middle-income countries
44. When Global ART Budgets Cannot Cover All Patients, Who Should Be Eligible?
45. Ebola and beyond: Recent experiences in confronting the Ebola epidemic suggest principles for vaccine efficacy trials in challenging environments
46. Informed consent, the value of trust, and hedons
47. Using informed consent to save trust
48. Paternalism, French fries and the weak-willed Witness
49. Nudges and Noodges: The Ethics of Health Promotion—New York Style
50. The phantasm of zero suicide.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.